The home secretary emphasised the safety and immunogenicity of the two vaccines — Serum Institute of India’s Covishield and Bharat Biotech’s Covaxin — approved by the national regulatory authority.
“...It has been reported that unfounded and misleading rumours are circulating, in the social and other media, creating doubt about the safety and efficacy of these vaccines,” the letter read.
Bhalla said that such kind of scare mongering, particularly by vested interests, can create unwarranted doubts among people.
The government had launched the two vaccines across the country on January 16. On Monday, 334,679 beneficiaries were vaccinated through 7,171 sessions till 7.10 pm across all states and union territories. The total number of adverse events following immunisations were 348 and no severe case of such effects was reported, according to the health ministry.
Leading the states tally, Karnataka has so far vaccinated over 230,000 health workers. Odisha has vaccinated more than 177,000 beneficiaries, followed by Andhra Pradesh, which has given the shot to more than 155,000.
States including Haryana, Punjab, Rajasthan, Telangana, Uttar Pradesh and West Bengal, have administered the jab to more than 100,000 people each.
The health ministry, too, has launched a campaign to counter rumour mongering
around vaccines, including a message that uses the lyrics from a Kishore Kumar song: Kuchh toh log kahenge, logon ka kaam hai kehna…
A series of posters released by the health ministry had experts such as V K Paul of Niti Aayog saying, “You are aware that I have taken Covaxin and I have zero side-effects. Data shows that these two vaccines are safe safe safe.”
Another tagline is: “Bimari se darein, teeke se nahin (Be scared of the illness, not the vaccine).” And a message by Randeep Guleria, director of the All India Institute of Medical Sciences, New Delhi, goes, “If we want to get over this pandemic, socially and economically, vaccines are important…”
Prime Minister Narendra Modi, too, recently interacted with the vaccinators and beneficiaries of the Covid vaccine to share their experiences and dispel vaccine hesitancy among people.
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.